Perspective · 20 Dec 2024
Conference abstractPublished 2017
The role of NGAL, MMP-9 and NGAL/MMP-9 in brain tumors
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Brain tumors are tumors with clinical conditions that are mainly influenced by their location instead of their histopathological grade. Brain tumors have bad progression, because although various diagnostic and therapeutic modalities have been created to improve outcomes, the tumors still often recurs. Recently, neutrophil gelatinase-associated lipocalin (NGAL), which binds into the enzyme matrix metalloproteinase-9 (MMP-9) and forms the NGAL/MMP-9 complex, is found to play a role in the development of malignancies. Several studies have demonstrated that these substances are known to support the tumor development by degrading the basal membrane and extracellular matrix and allowing tumor angiogenesis, invasion and metastasis. In this article, we will discuss about the role of NGAL, MMP-9 and NGAL/MMP-9 in brain tumors. Further studies are needed to ensure that these substances can be utilized to monitor the outcome of patients with brain tumors in the future. PDF HTML
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Archives in Cancer Research.
Perspective · 20 Dec 2024
Chemotherapy: A Vital Treatment in the Battle Against Cancer
Perspective · 20 Dec 2024
Tumor Microenvironment: A Key Determinant of Cancer Progression
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalArchives in Cancer Research
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Yaumil Reiza”
